DEA denies allegations of improper talks with an anti-marijuana group during rescheduling, treats claims as "gossip" and requesting dismissal ...
As the federal government considers loosening restrictions on marijuana, the Drug Enforcement Administration is scheduled to ...
Every party that applied to argue against rescheduling marijuana has full standing to participate in an upcoming landmark ...
A DEA administrative law judge has denied MedPharm's motion to participate in the December 2 marijuana rescheduling hearing, deferring to DEA Administrator Anne Milgram's authority. MedPharm, a ...
The cannabis industry is concerned about the direction of regulations – and the DEA is still against the plant.
Schedule III drugs, as defined by the DEA, are "drugs with a moderate to low potential for physical and psychological ...
DEA and anti-cannabis group must respond to allegations of unlawful talks by November 25. Legal tensions rise ahead of ...